← Back to Patent Explorer
EP0479489A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Tripeptide antithrombotic agents

Assignee: Eli Lilly and Co
•
Filing: 1991-09-26
•
Granted: —
•
Expires: 2011-09-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Thrombin inhibitors represented by the formula as provided wherein A(C=O)- is, inter alia , phenylglycyl, cyclohexylglycyl, cyclohexenylglycyl, thienylglycyl or naphthylglycyl, wherein the α-amino group is preferably substituted by alkyl e.g. methyl or an alkoxycarbonyl, cycloalkoxycarbonyl or arylkoxycarbonyl group e.g. t-butyloxycarbonyl. A(C=O)- also represents an α-substituted acetyl group such as α-methoxyphenylacetyl; or a bicyclic group such as a tetrahydroisoquinolin-1-oyl group; or a 1-amino or (substituted amino) cycloalkylcarbonyl group such as 1-aminocyclohexylcarbonyl. Also provided are a method for inhibiting the formation of blood clots in man and animals by administering a thrombin inhibitor of the above formula and pharmaceutical formulations useful in the method.

Inventors

  • 👤 Paul David Gesellchen
  • 👤 Robert Theodore Shuman

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-05 11:25
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0802; C07K5/0812; A; A61; A61K; A61K38/00; A61K38/04; A61K38/06; A61P; A61P7/00; A61P7/02; C07K5/06; C07K5/06008; C07K5/06078; C07K5/06139; C07K5/06191; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 288 words
A compound of the formula wherein A is 1) a group of the formula wherein R is a phenyl group of the formula wherein a and a′ independently are hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, hydroxy, hydroxymethyl, amino, or aminomethyl; or R is thienyl, furyl, naphthyl, or naphthyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen, amino, mono- or di-(lower alkyl)amino, or hydroxy; or R is cyclohexadienyl, cyclohexenyl, cyclohexyl or cyclopentyl; R₁ is hydrogen, methyl or ethyl; B is lower alkyl, lower alkoxy, hydroxy, or an amino group of the formula -N(R₂)(R₃) wherein R₂ and R₃ independently are hydrogen or lower alkyl or R₂ is hydrogen and R₃ is acetyl, haloacetyl or an oxycarbonyl group of the formula R₄-O-C(O)- wherein R₄ is C₁-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₇ cycloalkyl, benzyl, nitrobenzyl, diphenylmethyl, or a phenyl group as defined above; provided that when R₁ is methyl or ethyl then B is other than methyl or ethyl or A is 2) 1-aminocyclohexyl or 1-aminocyclopentyl wherein the amino group is an -N(R₂)(R₃) group as defined above; or A is 3) a bicyclic group of the formula wherein Q is a one carbon radical represented by or a two carbon radical represented by -CH₂-CH₂-, Y is a one carbon radical represented by or a two carbon radical represented by provided that one, but not both, of Q and Y is or and, provided further that,only one of Q and Y is a two carbon radical; R₅ is hydrogen or an oxycarbonyl group as defined above; and R₆ is hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy; and the dotted circle within the 6-membered ring indicates that the ring is aromatic or a perhydro ring; and the pharmaceutically acceptable non-toxic salts thereof.
Claim 2
Dependent Claim 262 words
A compound of the formula wherein A is 1) a group of the formula wherein R is a phenyl group of the formula wherein a and a′ independently are hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, hydroxy, hydroxymethyl, amino, or aminomethyl; or R is thienyl, furyl, naphthyl, or naphthyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen, amino, mono- or di-(lower alkyl)amino, or hydroxy; or R is cyclohexadienyl, cyclohexenyl, cyclohexyl or cyclopentyl; R₁ is hydrogen, methyl or ethyl; B is lower alkyl, lower alkoxy, hydroxy, or an amino group of the formula -N(R₂)(R₃) wherein R₂ and R₃ independently are hydrogen or lower alkyl, or R₂ is hydrogen or lower alkyl and R₃ is acetyl, haloacetyl or an oxycarbonyl group of the formula R₄-O-C(O)- wherein R₄ is C₁-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₇ cycloalkyl, benzyl, nitrobenzyl, diphenylmethyl, or a phenyl group as defined above; 2) 1-aminocyclohexyl or 1-aminocyclopentyl wherein the amino group is an -N(R₂)(R₃) group as defined above; 3) a bicyclic group of the formula wherein q is a carbon to carbon bond or -CH₂-; Y is a carbon to nitrogen bond or -CH(R₈)-, and R₇ and R₈ are hydrogen or >C=O, provided that when R₇ is >C=O Y is a carbon to nitrogen bond, -CH(R₈) and R₈ is hydrogen, and q is -CH₂-; R₅ is hydrogen, lower alkyl, benzyl or an oxycarbonyl group as defined above; and R₆ is hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy; and the pharmaceutically acceptable non-toxic salts thereof; provided further that when R₁ is methyl or ethyl then B is other than methyl or ethyl.
Claim 3
Dependent Claim 13 words
The compound of claim 1 wherein A is a group of the formula
Claim 4
Dependent Claim 15 words
The compound of claim 3 wherein B is an amino group of the formula -N(R₂)(R₃).
Claim 5
Dependent Claim 16 words
The compound of claim 4 said compound being N-Boc-D-phenylglycyl-L-prolyl-L-arginal and the pharmaceutically acceptable non-toxic salts thereof.
Claim 6
Dependent Claim 16 words
The compound of claim 4 said compound being N-methyl-D-phenylglycyl-L-prolyl-L-arginal and the pharmaceutically acceptable non-toxic salts thereof.
Claim 7
Dependent Claim 21 words
The compound of claim 1 wherein A is a bicyclic group of the formula and the pharmaceutically acceptable non-toxic salts thereof.
Claim 8
Dependent Claim 11 words
The compound of claim 7 said compound being DL-1,2,3,4-tetrahydroisoquinolin-1-oyl-L-prolyl-L-arginine aldehyde sulfate.
Claim 9
Dependent Claim 11 words
The compound of claim 7 said compound being D-1,2,3,4-tetrahydroisoquinolin-1-oyl-L-prolyl-L-arginine aldehyde sulfate.
Claim 10
Dependent Claim 17 words
A compound as claimed in any of claims 1 to 9 for use as an antithrombotic agent.
Claim 11
Dependent Claim 32 words
A pharmaceutical formulation comprising as an active ingredient a compound as claimed in any one of claims 1 to 9, associated with one or more pharmaceutically acceptable carriers, excipients or diluents therefor.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag